
当地时间3月28日至30日,第75届美国心脏病学会科学年会(ACC.26)将在美国新奥尔良召开。这场全球心血管顶级学术盛会,特设15场突破性临床试验(Late-Breaking)重磅汇报,ACC联合国际三大顶刊(JACC、JAMA、NEJM)重磅研究及各类特色试验悉数登场。值得一提的是,在这一极具学术分量的核心环节,来自中国3家医疗机构(南京市第一医院、中国人民解放军东部战区总医院、中国医学科学院阜外医院)的5项研究成功入选,展现了中国心血管领域的科研实力与国际学术影响力。
(下文研究标题前缀数字编码,为ACC官方平台发布的研究条目编号)
01、美国心脏病学会(ACC)联合美国心脏病学会杂志(JACC) 最新临床试验
Joint American College of Cardiology/Journal of the American College of Cardiology Late-Breaking Clinical Trials
当地时间:3月28日,星期六,上午9:30 - 10:30
102-07. Ultrasound-facilitated Catheter-directed Thrombolysis Vs Anticoagulation Alone For Acute Intermediate-high-risk Pulmonary Embolism: Primary Results Of The HI-PEITHO Randomized Clinical Trial
超声辅助导管导向溶栓对比单纯抗凝治疗急性中高危肺栓塞:HI-PEITHO随机临床试验的主要结果
讲者:Stavros V 美国
102-09. Outcomes In Patients With Atrial Fibrillation Randomized To Receive Left Atrial Appendage Closure Or Oral Anticoagulation: Primary Results Of The CHAMPION-AF Clinical Trial
心房颤动患者随机接受左心耳封堵术或口服抗凝治疗的结局:CHAMPION-AF临床试验的主要结果
讲者:Saibal Kar 美国
102-11. Primary Left Ventricular Unloading In Anterior ST-Segment Elevation Myocardial Infarction (STEMI) Without Cardiogenic Shock: Results From The STEMI-Door To Unload Randomized Clinical Trial
非心源性休克的前壁ST段抬高型心肌梗死(STEMI)患者行早期左心室减载治疗:STEMI-Door To Unload随机临床试验结果
讲者:Navin Kapur 美国
02、美国心脏病学会(ACC)联合美国医学会杂志(JAMA) 最新临床试验 Ⅱ
Joint American College of Cardiology/Journal of the American Medical Association Late-Breaking Clinical Trials Ⅱ
当地时间:3月28日,星期六,下午3:45 - 4:45
105-07. Kardinal: A Phase 2 Study Of Tonlamarsen For The Treatment Of Uncontrolled Hypertension
Kardinal研究:Tonlamarsen治疗未控制高血压的2期临床研究
讲者:Luke Laffin 美国
105-11. Intensive Low-density Lipoprotein Cholesterol Targeting In Patients With Atherosclerotic Cardiovascular Disease
动脉粥样硬化性心血管疾病患者的强化低密度脂蛋白胆固醇达标治疗
讲者:Byeong-Keuk Kim 韩国
105-13. DASH-patterned Groceries to Reduce Blood Pressure Among Adults With Treated Hypertension: Results From The GoFreshRx Randomized Clinical Trial
DASH模式膳食供给干预,降低接受治疗的成年高血压患者血压:GoFreshRx随机临床试验结果
讲者:Stephen Paul Juraschek 美国
03、美国心脏病学会(ACC)联合新英格兰医学杂志(NEJM) 最新临床试验 Ⅲ
Joint American College of Cardiology/New England Journal of Medicine Late-Breaking Clinical Trials Ⅲ
当地时间:3月29日,星期日,上午8:30 - 9:30
106-07. Controlled Trial Of High-Risk Coronary Intervention With Percutaneous Left Ventricular Unloading (CHIP-BCIS3)
经皮左心室减载辅助高危冠状动脉介入治疗的对照试验(CHIP-BCIS3)
讲者:Divaka Perera 英国
106-09. A Large-scale, Global Randomized Trial Of Coronary Physiology Derived From Conventional Angiography Compared With An Invasive Pressure Wire-based Approach To Guide Percutaneous Coronary Intervention
常规造影衍生冠状动脉生理学指标对比有创压力导丝技术指导经皮冠状动脉介入治疗:一项大规模全球随机对照试验
讲者:Ajay J. Kirtane 美国
106-11. A Randomized, Placebo-controlled Trial Of Chronic Total Occlusion Percutaneous Coronary Intervention In Stable Angina- ORBITA-CTO Trial
稳定型心绞痛患者慢性完全闭塞病变经皮冠状动脉介入治疗的随机、安慰剂对照试验 ——ORBITA-CTO试验
讲者:Sarosh A. Khan 英国
106-13. Fractional Flow Reserve Or 3d-quantitative Coronary Angiography-based Vessel-Ffr Guided Revascularization - The Fast Iii Trial
血流储备分数或基于三维定量冠状动脉造影的血管血流储备分数指导血运重建治疗 ——FAST Ⅲ试验
讲者:Joost Daemen 荷兰
最新临床试验
01、最新临床试验 Ⅳ
Late-Breaking Clinical Trials Ⅳ
当地时间:3月29日,星期日,上午10:45 - 11:45
107-07. Spironolactone In The Treatment Of Heart Failure
螺内酯在心力衰竭治疗中的应用
讲者:Frank Edelmann 德国
107-09. Efficacy And Safety Of Sotatercept In Combined Post- And Pre-capillary Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction: Results From The Phase 2 Cadence Trial
索特西普治疗射血分数保留心力衰竭相关的联合型前后毛细血管肺动脉高压的有效性与安全性:2期Cadence试验结果
讲者:Mardi Gomberg-Maitland 美国
107-11. Lung Impedance-guided Therapy In Heart Failure With Preserved Ejection Fraction: Results Of A Randomized Clinical Trial
肺阻抗指导下的射血分数保留心力衰竭治疗:一项随机临床试验结果
讲者:Michael Kleiner Shochat 以色列
107-13. Mavacamten In Symptomatic Adolescent Patients With Obstructive Hypertrophic Cardiomyopathy: Results From The Phase 3 Scout-HCM Trial
玛伐凯泰治疗有症状的青少年梗阻性肥厚型心肌病患者:3期SCOUT-HCM试验结果
讲者:Joseph William Rossano 美国
02、最新临床试验 V
Late-Breaking Clinical Trials V
当地时间:3月29日,星期日,下午4:00 - 5:00
110-07. Redo-surgery Versus Transcatheter Valve-In-Valve For Mitral Bioprosthetic Dysfunction: The SURVIV Trial
二尖瓣生物瓣功能障碍:再次外科手术对比经导管瓣中瓣置换术——SURVIV试验
讲者:Dimytri Siqueira 巴西
110-09. Transcatheter Aortic Valve Implantation Without Routine Percutaneous Coronary Intervention: A Randomized Controlled Trial
不常规行同期经皮冠状动脉介入治疗的经导管主动脉瓣置入术:一项随机对照试验
讲者:Michiel Voskuil 荷兰
110-11. Protect The Head To Head Trial: Randomized Comparison Of Emboliner Embolic Protection Catheter Vs. Sentinel Cerebral Protection System During Transcatheter Aortic Valve Replacement
PROTECT头对头试验:经导管主动脉瓣置换术中Emboliner栓塞保护导管与Sentinel脑保护系统的随机对照研究
讲者:Adam B. Greenbaum 美国
110-13. Two-year Outcomes After Transcatheter Tricuspid Repair Without Cross-over In The Randomized Tri-fr Trial
无交叉设计的随机TRI-FR试验:经导管三尖瓣修复术后2年结局
讲者:Erwan Donal 法国
03、最新临床试验 Ⅵ
Late-Breaking Clinical Trials Ⅵ
当地时间:3月30日,星期一,上午8:30 - 9:30
111-07. Heartline Study: A Decentralized Randomized Trial of Apple Watch and iPhone-Facilitated AF Detection and Cardiovascular Outcomes in Older Adults Without Known Atrial Fibrillation
Heartline研究:针对无已知心房颤动的老年人群,开展的一项基于苹果手表与 iPhone辅助房颤筛查的去中心化随机临床试验
讲者:C. Michael Gibson 美国
111-09. Digoxin In Rheumatic Heart Disease: A Multi-center, Randomized, Double Blind, Placebo-controlled Trial
地高辛治疗风湿性心脏病:一项多中心、随机、双盲、安慰剂对照试验
讲者:Ganesan Karthikeyan 印度
111-11. Discontinuation Of β-blocker Therapy In Stabilized Patients After Acute Myocardial Infarction
急性心肌梗死病情稳定患者停用β受体阻滞剂治疗的相关研究
讲者:Joo-Yong Hahn 韩国
111-13. Effect Of Intensive Triglyceride Lowering With Olezarsen On Progression Of Coronary Atherosclerosis: A Coronary Cta Substudy Of The Essence-TIMI 73b Randomized Trial
Olezarsen强化降甘油三酯治疗对冠状动脉粥样硬化进展的影响:ESSENCE-TIMI 73b随机临床试验的冠状动脉CT血管造影亚组研究
讲者:Nicholas Marston 美国
04、最新临床试验 Ⅶ
Late-Breaking Clinical Trials Ⅶ
当地时间:3月30日,星期一,上午10:45 - 11:45
112-07. Primary Efficacy And Safety Results From The Phase 3 Sirolimus-coated Balloon For Infra-inguinal Peripheral Arterial Disease (SirPAD) Trial
西罗莫司涂层球囊治疗腹股沟下外周动脉疾病3期 SirPAD 临床试验:主要有效性与安全性结果
讲者:Stefano Barco 瑞士
112-09. Intravascular Ultrasound Guidance For Complex High-risk Indicated Procedures - The Ivus Chip Trial
血管内超声引导复杂高危指征介入手术 ——IVUS CHIP临床试验
讲者:Roberto Diletti 荷兰
112-11. Intravascular Ultrasound-guided Versus Angiography-guided Percutaneous Coronary Intervention In Unprotected Left Main Coronary Artery Disease - The Optimal Trial
无保护左主干冠状动脉疾病患者:血管内超声引导对比造影引导经皮冠状动脉介入治疗——OPTIMAL临床试验
讲者:Adrian Banning 欧洲心血管研究所
112-13. Ivus Or Angiography Guidance For Pci In Complex Coronary Bifurcation Lesions
复杂冠状动脉分叉病变行经皮冠状动脉介入治疗的血管内超声或造影引导策略
讲者:陈绍良 南京市第一医院,中国南京
特色临床研究
01、特色临床研究 I
Featured Clinical Research I当地时间:3月28日,星期六,中午12:00 -下午1:00
201-07. A Prospective Multicenter Registry To Define Coronary Vasomotor Disorders In Ischemia With Nonobstructive Coronary Arteries: Primary Results Of Discover Inoca
明确非阻塞性冠状动脉缺血患者冠状动脉血管舒缩功能障碍的前瞻性多中心登记研究:DISCOVER INOCA研究主要结果
讲者:Samit M 美国
201-09. Impact Of Ivabradine On Orthostatic Intolerance, Quality Of Life And Heart Rate In Post-covid Postural Orthostatic Tachycardia Syndrome: Results From The Recover-Autonomic Trial
伊伐布雷定对新冠后体位性心动过速综合征患者直立不耐受、生活质量及心率的影响:RECOVER-AUTONOMIC试验结果
讲者:Pam Taub 美国
201-11. Coronary Optical Coherence Tomography And Cardiac Magnetic Resonance Imaging To Determine Sex Differences In Underlying Causes Of Myocardial Infarction With No Obstructive Coronary Arteries
应用冠状动脉光学相干断层成像与心脏磁共振成像探讨非阻塞性冠状动脉心肌梗死病因的性别差异
讲者:Harmony R. Reynolds 美国
201-13. A Sham Controlled Randomised Trial Evaluating The Safety, Acceptability And Efficacy Of Autonomic Neuromodulation Using Trans-cutaneous Vagal Sensory Stimulation In Uncontrolled Hypertensive Patients
经皮迷走神经感觉刺激行自主神经调制治疗未控制高血压患者的安全性、接受度及有效性评估:一项假手术对照随机试验
讲者:Ajay K. Gupta 英国
02、特色临床研究 Ⅱ
Featured Clinical Research Ⅱ
当地时间:3月28日,星期六,下午1:30 -下午2:30
216-07. Effects Of Tirzepatide Compared With Dulaglutide On Expanded Cardiorenal Outcomes
替尔泊肽对比度拉糖肽对扩展心肾结局的影响
讲者:Steven E. Nissen 澳大利亚
216-09. Prevalence And Clinical Impact Of Hypercortisolism In Individuals With Resistant Hypertension: Primary Results From The Momentum Study
难治性高血压患者高皮质醇血症的患病率及临床影响:MOMENTUM研究主要结果
讲者:Deepak L. Bhatt 美国
216-11. Reliability Of CAC=0 To Exclude Coronary Plaque In Diverse Global Cohorts: A Global Probability Study Of Coronary Artery Disease (GPS-CAD) Analysis
冠状动脉钙化积分为0在全球多样人群中排除冠状动脉斑块的可靠性:全球冠心病概率研究(GPS-CAD)分析
讲者:Lohendran Baskaran 新加坡
216-13. Community-to-clinic Linkage Implementation Program To Prevent Hypertension In Barbershops
社区与诊所联动实施计划,预防理发店高血压
讲者:Joseph E. Ravenell 美国
03、特色临床研究 Ⅲ
Featured Clinical Research Ⅲ
当地时间:3月29日,星期日,下午12:15 -1:15
276-07. 10-year Follow-up Of Clopidogrel Vs Aspirin Monotherapy In Stable Coronary Artery Disease After Percutaneous Coronary Intervention With Drug-eluting Stent
药物洗脱支架行经皮冠状动脉介入治疗后,稳定性冠心病患者氯吡格雷与阿司匹林单药治疗的10年随访结果
讲者:Hyo-Soo Kim 韩国
276-09. Coronary CT Derived Fractional Flow Reserve-guided Management Of Patients With Stable CAD: 3-year Outcomes From A Multicentre, Pragmatic, Open-label, Randomised Controlled Trial In China
冠状动脉CT源性血流储备分数指导下的稳定性冠心病患者管理:中国一项多中心、实用性、开放标签、随机对照试验的3年结局
讲者:唐春香 中国人民解放军东部战区总医院,中国南京
276-11. Role Of Screening With Coronary Computed Tomography Angiography In Lipid Management In An Asymptomatic Chinese Population: A Community-based, Parallel-group, Open-label, Randomized Clinical Trial (RESPECT2)
冠状动脉CT血管造影筛查在无症状中国人群血脂管理中的作用:一项基于社区的平行组、开放标签随机临床试验(RESPECT2研究)
讲者:郭翔 中国人民解放军东部战区总医院,中国南京
276-13. Targeted Assessment In High-risk Patients With Diabetes To Identify Undiagnosed Heart Failure
高危糖尿病患者的靶向评估:用于识别未确诊心力衰竭
讲者:Daniel Taylor-Sweet 英国
04、特色临床研究 Ⅳ
Featured Clinical Research Ⅳ
当地时间:3月29日,星期日,下午1:45 -2:45
291-07. MUTTON-HF (Medically Utilized Tailored Traditional Foods To Optimize Nutrition In Heart Failure): A Randomized Controlled Trial Of An Indigenous Food Is Medicine Intervention
MUTTON-HF研究(医用定制传统食物优化心力衰竭营养方案):一项本土食物即药物干预措施的随机对照试验
讲者:Lauren A. Eberly 美国
291-09. NOTIFY-HF: A Randomised Pilot Trial Of Patient-facing Heartlogic Alerts In Heart Failure Patients
NOTIFY-HF研究:面向心力衰竭患者的心脏逻辑预警系统随机预试验
讲者:Joseph Assad 澳大利亚
291-11. Automated Notifications To Improve Referral And Treatment Of Severe Aortic Stenosis And Mitral Regurgitation: Outcomes From The Randomized Alert Trial
自动化预警通知优化重度主动脉瓣狭窄与二尖瓣反流的转诊及治疗:随机Alert试验研究结果
讲者:Wayne B. Batchelor 美国
291-13. A Randomized Controlled Trial Of A Novel Just-in-time Adaptive Mobile Application Intervention To Reduce Sodium Intake And Blood Pressure In Patients With Hypertension
新型即时自适应移动应用干预措施用于降低高血压患者钠摄入与血压的随机对照试验
讲者:Michael Dorsch 美国
05、特色临床研究 Ⅴ
Featured Clinical Research Ⅴ
当地时间:3月30日,星期一,上午8:30 - 9:30
321-07. The Role Of Atrial Pacing Support In Cardiac Resynchronization Therapy: A Non-inferiority Randomized Trial
心房起搏支持在心脏再同步化治疗中的作用:一项非劣效性随机试验
讲者:mauro biffi 意大利
321-09. Efficacy And Safety Of BHB/HRS-1893 In Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From A 12-week Phase 2 Study
BHB/HRS-1893治疗症状性梗阻性肥厚型心肌病的有效性与安全性:一项为期12周的2期临床研究结果
讲者:王丽梅 中国医学科学院阜外医院,中国北京
321-11. Two-Year Outcomes Of Transcatheter Tricuspid Valve Replacement For Severe Tricuspid Regurgitation: The TRISCEND II Randomized Trial
经导管三尖瓣置换术治疗重度三尖瓣反流的2年结局:TRISCEND Ⅱ随机临床试验
讲者:Vinod H 美国
321-13. Prehospital Heparin Administration In Patients With STEMI Undergoing Primary PCI
接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者的院前肝素应用
讲者:Misa Fister 斯洛文尼亚
探索性研究
01、探索性研究 I
Investigative Horizons I
当地时间:3月30日,星期一,上午10:45 -1:45
336-07. Efficacy And Safety Of Enlicitide Decanoate, An Oral Macrocyclic Peptide Inhibitor Of PCSK9, Compared With Bempedoic Acid, Ezetimibe, Or Bempedoic Acid Co-administered With Ezetimibe In Statin-treated Adults With Hypercholesterolemia: Phase 3 CORALreef AddOn Trial
已接受他汀治疗的高胆固醇血症成年患者中,PCSK9口服大环肽类抑制剂Enlicitide Decanoate,对比贝派地酸、依折麦布及贝派地酸联合依折麦布的有效性与安全性:3期CORALreef AddOn临床试验
讲者:Alberico L. Catapano 美国
336-09. Anti-inflammatory Actions And Safety Of The NLRP3 Inhibitor VTX3232 Alone Or In Combination With Semaglutide In Participants With Obesity: A Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Study
NLRP3抑制剂VTX3232单药或联合司美格鲁肽用于肥胖受试者的抗炎作用及安全性:一项 2a期、多中心、随机、双盲、安慰剂对照研究
讲者:Peter Libby 美国
336-11. Effect Of Anti-fibrotic Therapy On Regression Of Myocardial Fibrosis After Transcatheter Aortic Valve Implantation (TAVI) In Aortic Stenosis Patients With High Fibrotic Burden: The Reduce-MFA DZHK 25-trial
抗纤维化治疗对高纤维化负荷主动脉瓣狭窄患者经导管主动脉瓣置入术(TAVI)后心肌纤维化逆转的影响:Reduce-MFA DZHK 25临床试验
讲者:Miriam Puls 德国
336-13. Prospective Multi-center Clinical Trial Of Artificial-intelligence Analysis Of Retinal Images For Identifying Elevated Atherosclerotic Cardiovascular Risk
视网膜图像人工智能分析识别动脉粥样硬化性心血管病高危人群的前瞻性多中心临床试验
讲者:Michael V. McConnell 美国
02、探索性研究 Ⅱ
Investigative Horizons Ⅱ
当地时间:3月30日,星期一,下午12:15 -1:15
351-07. Safety And Preliminary Efficacy Of AAVrh.10hFXN (LX2006) Gene Therapy In Friedreich Ataxia Cardiomyopathy
AAVrh.10hFXN(LX2006)基因疗法治疗弗里德赖希共济失调心肌病的安全性及初步有效性
讲者:Ronald Crystal 美国
351-09. Effect Of Financial Support On Quality Of Life And Medication Adherence Among Low-income Patients Following Hospitalization For Heart Failure: The FUND-HF Trial
经济支持对心力衰竭住院后低收入患者生活质量及用药依从性的影响:FUND-HF临床试验
讲者:Ambarish Pandey 美国
351-11. Adaptive AI For Cardiovascular Event Adjudication: Identifying Cardiovascular Events Across Changing Definitions In The Odyssey And Euclid Trials
用于心血管事件判定的自适应人工智能:基于Odyssey与Euclid试验中动态变更的定义识别心血管事件
讲者:Sreekanth Vemulapalli 美国
351-13. Artificial Intelligence Based Screening For Structural Heart Disease Using An ECG: Results From The PREVUE-VALVE Study
基于心电图的人工智能筛查结构性心脏病:PREVUE-VALVE研究结果
讲者:Timothy Poterucha 美国
03、探索性研究 Ⅲ
Investigative Horizons Ⅲ
当地时间:3月30日,星期一,下午1:45 -2:45
366-08. Artificial Intelligence Model For Evaluating Surgical Techniques Of Cardiac Surgeons
用于评估心脏外科医师手术技术的人工智能模型
讲者:袁昕 中国医学科学院阜外医院,中国北京
366-10. The Npr1 Agonist Xxb750 In Heart Failure
利钠肽受体-1激动剂Xxb750在心力衰竭中的应用研究
讲者:Scott Solomon 美国
366-12. Safety And Preliminary Efficacy Of AAVrh.10hPKP2 (LX2020) Gene Therapy In PKP2- Arrhythmogenic Cardiomyopathy
AAVrh.10hPKP2(LX2020)基因治疗PKP2缺陷型致心律失常性心肌病的安全性及初步有效性
讲者:Victoria Parikh 美国
366-14. Durability Of Enlicitide For Lipid Lowering: On-treatment Analysis Of Data From CORALreef Lipids And CORALreef HeFH Trials
Enlicitide降脂疗效的持久性:CORALreef Lipids与CORALreef HeFH临床试验的治疗期数据分析
讲者:Ann Marie Navar 美国
366-16. Long-Term Survival Benefits And Disease Stabilization With Acoramidis In Patients With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Acoramidis用于转甲状腺素蛋白淀粉样变心肌病(ATTR-CM)患者的长期生存获益及病情稳定作用
讲者:Prem Soman 美国
ACC.26会议期间,《国际循环》将持续追踪会场前沿动态、重磅研究成果与专家独家解读,更多精彩内容,敬请期待......
我要留言